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J. M. J, LAMERS, D. H. W. DEKKERS, N. DE JONG, AND J T. A. MEIJ. Modification of Fatty Acid Composition 
of the Phospholipids of Cultured Rat Ventricular Myocytes and the Rate of Phosphatidylinositol-4,5-Bis- 
phosphate Hydrolysis. Journal ojMo&cular and Cellular Cardiology (1992) 24, 605-618. Cultured neonatal cardiac 
myocytes have been utilized as a model for the study of the role of fatty acids in the or,-adrenoceptor mediated 
phosphatidylinositol turnover. Experiments were started 24h after seeding, when there was a confluent 
monolayer of beating cardiomyocytes. The cells were incubated for 3-4 days in sera containing culture medium 
with (1) no additives or (2) a mixture of 107 FM 18:0 and 18:ln-9, or (3) only 214 PM 18:2n-6 or (4) 214 PM 
20:5n-3. No differences in the cellular content of the various phospholipid classes among the different groups of 
fatty acid treated cells were found. The predicted elevations of 18:ln-9, 18:2n-6 and 20:5n-3 associated with a 
partial depletion of 20:4n-6 were confirmed in all phospholipid classes, except for sphingomyelin. The mol % of 
18:0, 18:2n-6, 20:4n-6 and 20:5n-3 in the phosphatidylinositol fraction were respectively 39, 4, 30 and 0.6 for 
the control treated cells, 34, 3, 15 and 0 for 18:0/18:1n-9 treated cells, 40, 17, 24 and 0.2 for the 18:2n-6 treated 
cells and 41, 3, 13 and 21 for the 20:5n-3 treated cells. Apart from the observed reductions in the basal rates, the 
phenylephrine (30~~) stimulated production of inositolphosphates was reduced by 51% and 71% , respectively 
in the 18:2n-6 and 20:5n-3 treated cardiomyocytes. The basal rate of inositolphosphate formation was 37 % 
increased in the 18:0/18:1n-9 treated cells. The [3H]-. mositol incorporation into phosphatidylinositol 
4,5-b&phosphate was only slightly reduced by 18:2n-6 and 20:5n-3 treatments (respectively 12 and 28% 
compared to control treated cells). Prolonged (30 n-tin) cs-adrenergic stimulation did not affect the contents and 
fatty acid profiles of any class of phospholipid, not even phosphatidylinositol. In conclusion, variations in the 
polyunsaturated fatty acid composition of membrane phospholipids do affect the basal and the at-adrenoceptor 
stimulated rate of phosphatidylinositol-4,5-bisphosphate hydrolysis. The reducing effects of 18:2n-6 and 20:5n-3 
treatment on the rate of inositolphosphate production may be partially ascribed to altered levels of phosphatidyl- 
inositol 4,5-bisphosphate. 
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‘Introduction understand the consequences of such 
The fatty acyl composition of cell membranes modification in terms of membrane phospho- 
can be markedly altered by dietary means, lipid dynamics and function. Dietary n-3 poly- 
especially by changing the degree of poly- unsaturated fatty acids (n-3 PUFA) have been 
unsaturation. For this reason it is important to shown to result in a reduction of the (Y)- but 
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not of the /3-adrenoceptor mediated changes in 
cardiac inotropy (Reibel et al., 1988) and so 
the question arises whether the difference in 
the crt-adrenergic response after incorporation 
of those PUFA into heart membranes is 
caused by alterations’ in the rate of 
phosphatidylinositol-4,5-bisphosphate (PIP,) 
breakdown by specific phospholipase C. A 
massive incorporation of eicosapentaenoic 
acid (20:572-3) and docosahexaenoic acid 
(22:6n-3) at the expense of linoleic acid 
(18:2n-6) and arachidonic acid (20:4n-6) was 
observed in the cardiac total phospholipid 
fraction from rats fed with n-3 PUFA (Reibel 
et al., 1988). Changes in platelet responsive- 
ness to aggregating substances induced by 
intervention with dietary n-3 PUFA have 
usually been related to alterations in the 
production of eicosanoid precursor fatty acids 
and not merely to alterations in the fatty acid 
composition of membrane phospholipids 
(Hartog et al., 1987; Lamers et al., 1987 and 
Leaf and Weber, 1988). However, Medini et 
al. (1990) demonstrated that dietary 20:5n-3 
modulated the pathway of inositol-1,4,5-tris- 
phosphate (IPs) generation in platelets from 
rabbits independent of modification of 
thromboxane production. Likewise, Reibel et 
al. (1988) showed that changes in eicosanoid 
production induced by dietary fish oil were 
not likely involved in the attenuation of the 
myocardial crl-adrenoceptor response. 
In vivo studies (Gudbjarnason et al., 1978 
and Montfoort et al., 1986) have indicated that 
chronic noradrenaline stress produces changes 
in n-3 relative to the n-6 PUFA content of 
myocardial phospholipids, particularly that of 
the phosphatidylethanolamine fraction. It is 
not known whether this noradrenaline 
treatment effect is a direct (pi- or fl-adrenergic 
effect on the myocardial cells or an indirect ol- 
or @adrenergic effect resulting from altered 
lipid metabolism in the liver. Nevertheless, 
the accelerated turnover of the myocardial 
(polyphospho)PI lipids, induced by czi- 
adrenoceptor stimulation, could be one of the 
factors involved in the in vivo effects of nor- 
adrenaline stress on myocardial phospho- 
lipids. 
Several reports have described that the fatty 
acid composition of culture cardiomyocytes 
can be modified by addition of non-esterified 
fatty acids (NEFA) to the culture medium 
(Grynberg et al., 1988; Meij et al., 1990; 
Nalbone et al., 1990; Hallaq et al., 1990). 
These cells, isolated from neonatal rat hearts, 
beat spontaneously with a regular rhythm and 
amplitude of contraction and can be incubated 
free from circulating agonists (Meij and 
Lamers, 1989a and b). They maintain their 
function for several days in culture medium, 
which allows time for incorporation of long- 
chain (polyunsaturated) fatty acids into the 
phospholipids of their cell membranes. 
Recently, we showed that 20:5n-3 as well as 
18:2n-6 treatment of cultured heart cells had 
no effect on the basal and oi-adrenoceptor 
stimulated PIP2 hydrolysis (Meij et al., 1990). 
However, in this study only minor changes 
occurred in fatty acid composition of the 
phospholipids (e.g. the maximal n-3/n-6 
PUFA molar ratio amounted 0.45). Nalbone 
et al. (1990) showed increases of the n-3/n-6 
PUFA molar ratio up to 1.1 in cultured 
cardiomyocytes, very near to values reported 
in the study of Reibel et al. (1988). 
In the present study, we investigated the 
effect of NEFA supplements to the serum in 
the primary culture of rat cardiomyocytes on 
the fatty acid composition of the various 
phospholipid classes, with particular attention 
to the PI fraction. The main object was to 
observe the influence of these changes on the 
rate of basal and crl-adrenoceptor mediated 
PIP2 hydrolysis. We also evaluated the 
possible effects of long-term cr-adrenergic 
stimulation of the PI turnover on the fatty acid 
composition of the PI fraction as well as all the 
other phospholipid classes. 
Materials and Methods 
Chemicals 
Growth medium: Nutrient mixture Ham F10 
(Gibco, Scotland) supplemented with 10 % v/v 
fetal calf serum, 10% v/v horse serum, 200 
U/ml penicillin, 0.2 mg/ml streptomycin (all 
from Boehringer, Mannheim, FRG) and 135 
pg/ml CaClz.2HzO; Petri dishes (TC 35110 
and TC 60/15) were from Greiner (Niirtin- 
gen, FRG); four-well multidishes were from 
Nunc (Denmark); trypsin (type III) was from 
Sigma as were the 18:ln-9, 18:2n-6 and 
20:5n-3, the BF$methanol and the lipid 
standards phosphatidylcholine (PC), phospha- 
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tidylethanolamine (PE), phosphatidylinositol 
(PI), phosphatidylserine (PS), sphingomyelin 
(SPM) and lysophosphatidylcholine; 18:0 was 
from BDH (Poole, England); standard fatty 
acid methylesters and the internal standard 
heneicosanoic acid (21:0) for the transmethyl- 
ation reaction were from Alltech Ass., Inc 
(Deerfield, USA); [2-3H]-myoinositol was 
from Amersham International PLC 
(Amersham, UK); [dipalmitoyl-lJ4C]-PC and 
EN3HANCE spray were from NEN (Boston, 
USA); phenylephrine HCl was from Brocades 
(Delft, The Netherlands); Thin layer 
chromatography plates (Kieselgel 60 F-254) 
were from Merck (Darmstadt, FRG), Dowex 
l-X8 (100-200 mesh, formate form) from 
BioRad Labs (California, USA) and Instagel 
was from Packard (Groningen, The 
Netherlands); Triacylglyceride and glycerol 
test kits (respectively, GPO-PAP and 
Precimat@ glycerol) were from Boehringer 
(Mannheim, FRG). All other chemicals were 
of analytical grade. 
Primary heart cell culture 
Cardiomyocytes were isolated from the 
ventricles of 2-4-day-old Wistar rats by tryp- 
sinization and grown according to Yagev et al. 
(1984). We applied a modified enrichment 
method of two successive periods of 30 and 90 
min plating (Blonde1 et al. (1971); Meij and 
Lamers (1989a and b)). Of the final 
suspension containing 9 x lo5 myoblasts per 
ml, 2 ml were seeded per TC 35/10 Petri dish, 
6ml per TC 60/15 Petri dish and 0.6ml per 
well in 4-well multidishes. After 24h 
incubation (37’C, 5% C02, 95% humidity) 
this resulted in a confluent monolayer of 
beating cardiomyocytes. About 24 h after 
seeding the growth medium was replaced by 
conditioned medium (Table 1). 
TABLE 1 Total and non-esterified fatty acid content (pM) of the conditioned media 
Fatty Control 18:0/18:ln-g 18:2n-6 
acid 
20:5n-3 
16:0 
18:0 
18:ln-9 
18:2n-6 
20:4n-6 
20:5n-3 
22:5n-3 
22:5n-6 
Total” NEFAb Total NEFA Total NEFA Total 
PM FM A@ A/&I ‘W APM APM 
221 9.8 7 0.5 -2 - 0.5 6 
226 5.9 80 104 - 33 - 0.8 - 10 
221 7.5 125 104 -3 -0.1 18 
410 5.9 -5 0 208 218 - 11 
19.4 0.2 0.7 0 3.2 0.1 2.7 
n.d.d n.d. n.d. n.d. n.d. n.d. 201 
5.2 n.d. 0.1 n.d. 0.1 n.d. 0.6 
6.5 n.d. 0.9 n.d. 1 n.d. 1.2 
NEFA 
‘W 
-0.2 
- 0.2 
0.6 
-0.1 
0.1 
215 
n.d. 
n.d. 
CPUFA” 441 6.1 -3 0 211 218 215 215 
“Fatty acid content of the culture medium containing fatty acids esterified in phospholipids, cholesterolesters. TG and 
NEFA. 
bNEFA stands for the non-esterified fatty acid fraction. 
‘CPUFA is the sum of PUFA. 
dn.d. means non-detectable. 
eAp~ is the change of total fatty acid or NEFA concentration versus control medium, The data represent the mean of 
duplicate measurements. 
Cell incubations medium which was supplemented with 214 FM 
At the beginning of each experiment the batch 18:2n-6; (4) 20:5n-3 rich medium which was 
of dishes was divided into four sets, each set supplemented with 214 gM 20:5n-3 (Table 1). 
receiving one of the following conditioned The ethanolic fatty acid solutions were mixed 
media: (1) control medium; (2) 18:0/18:1n-9 under vigorous stirring with the concentrated 
rich medium which was supplemented with calf and horse sera (containing excess of fatty 
18:0 and 18: ln-9, 107 PM each; (3) 18:2n-6 rich acid poor albumin molecules) followed by 
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addition of the Ham FlO medium. Because 
the non-esterified fatty acids (NEFA) were 
dissolved in ethanol when added to the sera 
during preparation of each medium, control 
medium contained an equal concentration 
(0.3 % v/v) of pure ethanol. Fresh conditioned 
media were given to each set after 65 h. 
Furthermore every medium was supple- 
mented with either 88nM unlabelled myo- 
inositol or - to study [3H]-inositolphosphate 
formation - 88 nM [2-3H]-myoinositol (2 &i/ 
ml). The dishes were then incubated with 
those fresh media for at least 24h (37’C, 5% 
CO?, 95% humidity) before starting the cell 
stimulation. In the [3H]-IP, formation studies 
small dishes (type 35/10) were used and for the 
lipid and fatty acid analysis large dishes (type 
60/15) were used. For the study of 
[3H]-inositol incorporation into PI, PIP and 
PIP, 4-well multidishes were used. 
Cell stimulation and assay of 
[ 3H] -inositolphos#utes 
After 24 h preincubation of the cardio- 
myocytes with [3H]-myoinositol in the con- 
ditioned culture medium, the dishes were 
rinsed twice with 1 ml buffer (130mM NaCl, 
4.7mM KCI, 1.3 mM CaC12, 20 mM 
NaHCOs, 0.44 mM NaH2P04, 1.1 mM 
MgC&, 0.2% w/v glucose, pH 7.4, equi- 
librated at 37% with 5% CO, at 9: To 
humidity) and the cells were equilibrated in 
this buffer for 30 min. Then LiCl was added to 
a final concentration of 10mM. After another 
10min of preincubation, phenylephrine at a 
final concentration of 30/,&M, or buffer was 
added to a final volume of 1 ml. Incubations 
were terminated after 30min by rinsing the 
small dishes with 0.5 ml cold buffer followed 
by the addition of 0.5ml cold methanolll2M 
HCl(lO0: 1, v/v). The cells were scraped using 
a rubber policeman and the suspension was 
collected in a glass tube. The dish was rinsed 
once more with 0.5 ml of methanol/l2 M HCl, 
which was transferred to the same glass tube. 
Then 1 ml chloroform and 0.5 ml 2.5M HCl 
were added to the tube. After centrifugation 
(lOmin, 155Og) the upper phase, containing 
the IP,, was collected and the lower phase was 
washed once with 1.5 ml methanol/chloro- 
form/O.6M HCl (48:3:47, v/v/v). The upper 
phases were combined and 5 ml distilled water 
was added. The IP, were separated by anion 
exchange using 1 ml Dowex 1 -X8 according to 
the method of Berridge et al. (1982). Briefly, 
free inositol and glycerophosphoinositides 
were eluted with 10ml distilled water and 
10ml 5 mM disodiumtetraborate in 30 mM 
sodiumformate respectively. Inositolmono- 
phosphate (IP), inositolbisphosphate (IP2) and 
inositoltrisphosphate (IPX) were eluted all 
together using loml l.oM ammonium 
formate in 0.1 M formic acid. One volume of 
the eluate was mixed with one volume of 
Instagel and counted for radioactivity by 
liquid scintillation (Tri-carb 2660, from 
Packard, Groningen, The Netherlands). 
Separation of lipids and quant$cation of fatty acid 
methylesters 
For studying the incorporation of [3H]-inositol 
into PI, PIP and PIP? of control and fatty acid 
treated cardiomyocytes, cells from 4-well 
multidishes were rinsed twice with 0.5 ml ice- 
cold Ham FlO medium without sera. 
Thereafter the cells were scraped off and 
extracted with the methanol/HCl procedure 
(Meij and Lamers, 1989b). The washed lower 
organic phase was evaporated to dryness with 
NP, redissolved and spotted on TLC plates 
previously impregnated with 1% potassium- 
oxalate in methanol/H20 (2:3, v/v) and 
activated for 30 min at 110%. The plates were 
developed as previously described (Meij and 
Lamers, 1989b). After development the plates 
were dried and sprayed with EN3HANCE to 
visualize the radioactive spots by fluorography 
(Kodak SB5). The different inositol contain- 
ing spots, identified by co-elution of authentic 
standard (polyphospho)PI lipids, were 
scraped off and counted for radioactivity by 
liquid scintillation. 
For studying the lipid composition of the 
treated unlabelled cells, the cell incubations 
containing unlabelled myoinositol were 
terminated after 30min by rinsing the large 
dishes with 1.5 ml cold buffer, followed by the 
addition of 1.5 ml cold methanol. The cells 
were scraped using a rubber policeman and 
the suspension was collected in a glass tube. 
The dish was then rinsed again with 1.5 ml of 
methanol. After addition of 1.5 ml chloro- 
form, the suspension was stored under nitro- 
gen at - 20% overnight. For the estimation 
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of the recovery of total phospholipids, tracer 
amounts of [‘+C]-PC were added. The phases 
were then separated by adding chloroform 
and 0.1 M KC1 to a final ratio of 2:2: 1 (v/v/v) 
and centrifugation (lOmin, 155Og), according 
to Bligh and Dyer (1959). The organic lower 
phases of the two extracts were combined. 
Approximately 0.40-0.75ml of the com- 
bined lipid extracts were used for the separ- 
ation of total phospholipid and TG fractions 
from other lipids by thin layer chromato- 
graphy, using activated plates and hexaneldi- 
ethylether/acetic acid (60:40: 1, v/v/v) as 
solvent system and 0.02% w/v butylated 
hydroxytoluene (BHT) as an antioxidant, 
The phospholipid spot remaining at the origin 
was scraped off and extracted twice with 
1.5 ml methanol. 
For the separation of various phospholipid 
classes, about 5ml of the combined extracts 
were evaporated to dryness with Ns at 37% 
and redissolved in a small volume of organic 
solvent. The samples were applied under N2 
to an activated (30min, 110%) TLC plate. 
The plates were developed with the solvent 
chloroform/methanol/petroleum ether (bp 40- 
60%)/acetic acid/boric acid (40:20:30: 
14: 1.8, vlvlvivw) containing 0.02% (w/v) 
BHT by a modified method A .Xhillan ei al. 
(1983). The spots were visualized by spraying 
with Rhodamine 6G (0.01%). The individual 
phospholipids were identified by co-migration 
of standards. The plate was dried under N, 
and the scraped spots were extracted twice 
with 1.5 ml methanol for fatty acid analysis. 
After addition of 20nmol of the internal 
standard 21:0 to the extracted phospholipid 
fractions, the methanol was evaporated under 
Nz and the phospholipids were transmethyl- 
esterified using BFs as previousIy described by 
Morrison and Smith (1964). For the gas 
chromatographic separation of the fatty acid 
methyl esters a CP9000 capillary column 
chromatograph (Chrompack, Middelburg, 
The Netherlands), equipped with a CP-Si188 
coated fused silica capillary column, was used. 
The separated peaks were identified on the 
basis of the retention times as compared to 
standards (Montfoort et al., 1986). 
Analysis of TG and &verol 
TG was measured spectrophotometrically in 
the initial lipid extracts using the test kit. For 
the study of glycerol release, the incubation 
media were collected just before the wash step 
at the end of the cell incubations. Glycerol was 
measured fluorimetrically according to the 
method of Laurel1 and Tibbling (1966). 
Statistical analysis 
All data are expressed as means f  LE.. Mul- 
tiple comparisons were made between control 
and fatty acid treated cells by unpaired 
Student’s t-test with PCO.05 being considered 
significant. 
Results 
Fat0 acid composition oj mmzbrane phospholipids 
The effects on membrane composition were 
examined in cardiomyocytes isolated from 
neonatal rats that were incubated for 3-4 days 
in animal sera containing culture medium 
with (1) no additives or (2) a mixture of 
107~~ 18:0 and 107lM 18:ln-9, or (3) only 
214~~ 18:2n-6 or (4) 214~~ 20:5n-3. Table 1 
shows the total fatty acid and NEFA content in 
pM of the four conditioned media. 
Supplementation of the media with NEFA 
changed the total fatty acid content of the 
media only moderately (not more than 20% 
increase). The total pool of fatty acids is 
mainly composed of those esterified in TG, 
cholesterolesters and phospholipids which are 
all present in the lipoproteins of the added 
sera. However, it is important to note that the 
small NEFA pool constituting 2-3s of the 
total fatty acid pool, generally serves as the 
major extracellular source of fatty acid for 
cultured cells (Spector et al., 1981). As can be 
seen in the NEFA fraction of the conditioned 
media, the 18:0, 18: ln-9, 18:2n-6 and 20:5n-3 
contents have changed drastically due to the 
additions (Table 1). The results of the analysis 
of cardiomyocyte phospholipids under the 
influence of these various fatty acid supple- 
ments are shown in Table 2. 
There was no detectable change due to fatty 
acid treatment of the cardiomyocytes in the 
relative or absolute amounts of phosphatidyl- 
choline (PC), phosphatidylethanolamine 
(PE), phosphatidylinositol (PI) and sphingo- 
myelin (SPM) fractions separated by one-di- 
mensional thin-layer-chromatography (TLC). 
The composition is similar to that reported by 
Post et al. (1988) for cultures of neonatal 
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TABLE 2 Class composition of total phospolipids from control cardiomyocytes and cells treated with 
18:0/18:ln-g, 18:2n-6 or 20:5n-3 
Class of Control 
phospholipid fZ=6” 
18:0/18:ln-g 18:2n-6 20:5n-3 
n=2 n=5 n=4 
mol pmnkage (S. E.) 
PC 45.9 (5.0) 48.8 44.4 (4.4) 52.0 (5.1) 
PE 30.9 (3.3) 30.0 31.8 (4.8) 27.2 (3.6) 
PS 4.0 (0.6) 4.4 5.3 (1.4) 4.9(1.1) 
PI 9.0 (1.2) 9.1 9.4 (1.0) 8.5 (0.8) 
SPM 10.1 (2.3) 7.7 9.1(1.2) 7.2 (1.7) 
The composition is calculated from gaschromatographic analysis of the prepared methylesters of the fatty acids 
constituting the respective phospholipid classes. No differences were found between the respective absolute 
phospholipid fatty acid contents (respectively 191 f  10, 178, 178 f  9 and 202 nmoUmg protein) of control-, lE:O/lE:ln-Q-, 
18:2n-6- and 20:5n-3 treated cardiomyocytes. Values are presented as means (SE.). 
aNumber of determinations of the phopholipid class contents in each group of control or fatty acid treated cells. 
cardiomyocytes except that in the present 
study PI and PS were determined separately. 
Since the amounts of the phospholipid classes 
were found to be the same in all four cell treat- 
ments, it was decided to express the results of 
fatty acid composition in mol% . The results of 
the fatty acid analysis of the major phospho- 
lipid fractions PC and PE are shown in Table 
3. 
Supplementation of the culture medium 
with 18:0/18:1n-9 mixture caused a marked 
increase in incorporation of these fatty acids in 
PC and predominantly a reduction in 16:0, 
18:ln-7 and 20:4n-6 and the sum of PUFA 
decreased from 33.9 to 24.7 mol % . However, 
the n-3/n-6 PUFA molar ratio decreased from 
0.17 to 0.11 resulting from a slight shift in 
incorporation of n-6 PUFA in favor of n-3 
PUFA. Treatment of the cells with 18:2n-6 
caused a dramatic increase of 18:2n-6 to 42.1 
mol% of the total PC fatty acids and a 
decrease of incorporated 18:2n-6 metabolites, 
20:4n-6 and 22:4n-6 (Table 3). There was still 
a marked increase of CPUFA from 33.9 to 
49.9 mol% . The massive incorporation of 
18:2n-6 into the fatty acids of PC, depressed 
the n-3/n-6 PUFA molar ratio to almost zero. 
Treatment of the cardiac cells with 20:5n-3 led 
to increased incorporation of this fatty acid 
and also of 22:5n-3 in PC. The increased 
incorporation of n-3 PUFA occurred at the 
expense of n-6 PUFA as the sum of 18:2n-6 
and 20:4n-6 decreased from 26.5 to 12.6 
mol% , Although CPUFA increased signific- 
antly from 33.9 to 41.5 mol% after 20:5n-3 
treatment, the increase was much less 
compared to 18:2n-6 treatment. Thus it 
appeared that cardiomyocyte PC more readily 
incorporated 18:2n-6 than 20:5n-3. 
The general patterns of changes in phos- 
pholipids PE, PI and PS following fatty acid 
treatment of the cells were very similar to 
those seen in PC (Tables 3 and 4). Tliere are, 
however, some interesting differences between 
the fatty acid composition of the various 
phospholipid classes per se and some phospho- 
lipid class-specific responses to fatty acid treat- 
ment. The preferential incorporation of 
18:2n-6 compared with 20:4n-6, 20:5n-3 and 
22:5n-3 was observed predominantly with PC, 
as the highest 18:2n-6 incorporation among 
the other phospholipid classes was certainly 
less than 22 mol%. This difference between 
PC and the other phospholipid classes PE, PI 
and PS can not be explained by the low PUFA 
contents of the non-PC phospholipid classes; 
on the contrary, the CPUFA of e.g. PE of 
control treated cells reaches almost 50mol% 
(Table 3). 
The results in Tables 3 and 4 show that PE, 
PI and even PS in control treated cells contain 
much more 20:4n-6 relative to 18:2n-6 (e.g. PI 
contains 30.0 relative to 4.4 mol%). Another 
remarkable finding is the relative homo- 
geneity in fatty acid composition of the PI 
fraction in control treated cardiomyocytes. 
The PI fraction is mainly composed of mole- 
cular species with 18:0 on the sn-1 site and 
20:4n-6 on the m-2 site of the glycerol moiety. 
This homogeneity disappeared when the 
cardiomyocytes are exposed to the various 
types of fatty acid. It should also be noticed 
that in the PS fraction, in contrast to the other 
major phospholipid classes, there is a prefer- 
ential incorporation of the 20:5n-3 metabolite 
22:5n-3. 
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TABLE 5 Fatty acid composition (mol %) of the sphingomyelin fraction from control cardiomyocytes and 
cells treated with 18:0/18:ln-g, 18:2n-6 or 20:5n-3 
Fatty 
acids 
Control 
n = 4” 
18:0/18:ln-g 18:2n-6 20:5n-3 
n=2 n=4 R = 3 
16:O 26.6 (1.3) 22.1 28.5 (2.2) 36.3 (2.2)d 
18:0 19.1 (1.5) 28.5 17.4 (1.7) 15.5 (3.3) 
18: ln-9 4.0 (0.5) 5.6 4.2 (0.9) 4.4 (1.0) 
18:2n-6 2.7 (0.9) 0.6 3.9 (1.3) 1.0 (0.0) 
20:o 9.2 (0.6) 8.5 8.8 (0.6) 6.6 (0.1) 
22:o 9.1 (0.7) 10.1 8.4 (1.2) 7.8 (1.0) 
20:4n-6 3.8 (0.8) 2.3 4.7 (1.2) 3.3 (0.2) 
24~0 10.5 (1.0) 11.1 7.6 (0.5)d a.2 (1.1)) 
20:5n-3 0.8 (0.4) n.d. 0.3 (0.0) 1.1 (0.1) 
24: ln-9 8.5 (0.7) 8.9 8.5 (0.8) 9.0 (1.0) 
other& 5.8 (0.9) 2.8 7.6 (2.4) 6.8 (,1.5) 
n-3/n-6c 0.40(0.11) 0.28 0.32 (0.13) 0.61 (0.05) 
CPUFA’ 9.6 (1.9) 3.6 11.8 (2.7) 7.6 (1.3) 
aNumber of determinations of the fatty acid content in each group of control or fatty acid treated cells. 
bOnly the major fatty acids are listed and the sum of minor fatty acids (mainly 16:Odma. 18:0dma, 18: ln-7, 18:3n-3) 
are listed and termed “others”. Dma is the abbreviation for dimethylacetal. 
‘N-3/n-6 is the molar ratio of total % of n-3 PUFA over the total of n-6 PUFA. 
dP<0.05 versus control cells. 
‘ZPUFA is the sum of all PUFA. Values are presented as means (S E ). 
SPM is a choline-containing phospholipid 
with only one fatty acid esterified per 
molecule. Long-chain (mono)unsaturates are 
reported to be mainly present. The results 
obtained from the cardiomyocyte are 
summarized in Table 5 and confirm this 
distinct SPM property as the 16:0, 18:0, 20:0, 
22:0, 24:0 and 24: ln-9 contents vary between 
8 and 27 mol% whereas the contents of 
18:2n-6 and 20:5n-3 were both lower than 
4 mol % Therefore it is not suprisingly that 
18:2n-6 or 20:5n-3 treatment of the cells did 
not lead to incorporation of these fatty acids 
into SPM. In contrast, slight changes in the 
24:0 content of SPM in response to 18:2n-6 
treatment and in the 16:0 and 20:0 content in 
response to 20:5n-3 treatment had occurred. 
The rate of PIP, hydrolysis 
The cardiomyocytes, pretreated with control 
medium and 18:0/18: ln-9, 18:2n-6 or 20:5n-3 
rich medium, were tested for the basal and 
ari-adrenoceptor stimulated rate of PIP, 
hydrolysis. The t3H]-IP, production (Fig. 1) 
represents the sum of [3H]-IP, [3H]-IP2 and 
t3Hl-IPs formation. Previously we have 
shown that the major IP, formed is the mono- 
phosphate, due to the rapid breakdown of IP, 
and IP3 by phosphatases during cell incub- 
ation. The IP, formation was measured over a 
period of 30 min. Cardiomyocyte exposure to 
18:0/18:1n-9 stimulates basal PIP, hydrolysis 
37% whereas partial inhibition was found 
after exposure to 18:2n-6 and 20:5n-3 (35 and 
49%) respectively). The maximal rate of PIP, 
hydrolysis that can be reached by adding 
30 pM phenylephrine was not significantly 
affected by 18:0/18:1 n-g treatment but was 
also partially inhibited by treatment with the 
n-6 and n-3 PUFA (51% and 71%, 
respectively). 
No selective depletion of any specific type of 
PUFA occurred in the PI fraction of the 
cardiomyocytes stimulated for 30min with a 
maximal dosis of phenylephrine [Fig. 2(a) and 
(b)]. Similarly, the analysis of non-PI 
phospholipids showed no changes in fatty acid 
patterns due to cll,-adrenergic stimulation 
(results not shown). 
[3H]-Inositol incorporation in membrane 
(polyphospho)PI lipids 
The [3H]-inositol incorporation into the 
membrane (polyphospho)PI lipids was 
measured during the final 24 h of the three 
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Cell treatmenl 
FIGURE 1. The basal rate and cr,-adrenoceptor medi- 
ated phosphatidylinositol-4,5-bisphosphate breakdown of 
control cardiomyocytes and cells treated with 
18:0/18:1n-9, 18:2n-6 or 20:5n-3. The incubation time 
was 30min and the phenylephrine concentration for 
stimulation of the PI cycle was 30fiM. The columns are 
means, bars are S.E., of [3H]-IP, formation expressed as 
% of the unstimulated control value in 7 experiments. 
‘PeO.05 us unstimulated control treated cells; ‘P<O.O5 
US stimulated control treated cells; +P<O.O5 us stimulated 
18:0/18:1n-9 treated cells. 
j 
I 
, I 
! 
i i 1 
l-?LJl 
16:O 18:1 I 6: 20-6 20:4,,-6 20:5n-3 22: 50-3 16:O 16:I 16:2n-6 20:4n-6 ZO:Jn-3 2215,~3 
Fatty acid 
FIGURE 2. The effect of no stimulation (a) or prolonged stimulation of PI cycle (b) on the fatty acid composition of 
the PI fraction from control cardiomyocytes and cells treated with 18:0/18:1n-9, 18:2n-6 or 20:5n-3. The incubation 
time was 30 min and the phenylephrine concentration for the stimulation was 30 FM. After incubating of the cells the 
phospholipids were extracted and PI separated by TLC. Only the major fatty acids are shown. The columns are means, 
bars at-e S.E. of mol% of the specific fatty acid of PI in 5 experiments. 
16:0/16:1 16:2n-6 20:5n-3 
cell trcotment 
FIGURE 3. The rate of lipolysis (a) and the triacylglyceride content (b) of unstimulated and phenylephrine-stimul- 
ated cardiomyocytes, control cells and cells treated with 18:0118:ln - 9, 18:2n-6 or 20:5n-3. Glycerol release as a 
measure of lipolysis was determined over an incubation period of 30min. The phenylephrine concentration for the 
stimulation of the PI cycle is 30~~. The columns are means, bars are S.E., of glycerol release and TG contents in 
respectively 4 and 5 experiments. 
‘W0.05 us control treated cells; “P<O.O5 us corresponding values of 18:0/18:1n-9 treated cells; +P<O.O5 US cor- 
responding value of 18:2n-6 treated cells. 
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TABLE 6 [3H]-inositol incorporation into (polyphospho)PI lipids of control cardiomyocytes and cells 
treated with 18:0/18:ln-g, 18:2n-6 and 20:5n-3 
Control 18:0/18:ln-g 18:2n-6 
PI, dpmb 
PI, %’ 
PIP, dpm 
PIP, % 
PIP,, dpm 
PIP,, % 
Sum, dpm 
Sum, % 
39346 w9 
93.2 (0.2) 
1381 (70) 
3.24 (0.19) 
1545 w-9 
3.58 (0.13) 
42062 (381) 
100 
38467 (831) 
93.9 (0.4) 
1263 (64) 
3.27 (0.16) 
1407 (57) 
3.38 (0.10) 
41439 (89’4 
100 
35022 (579) 
92.8 (0.3) 
1369 (94) 
3.71 (0.20) 
1351 (66) 
3.64 (0.12) 
37387 (508) 
100 
20:5n-3 
31112 (409) 
93.4 (0.3) 
1078 (53)" 
3.22 (0.16) 
1166 (36) 
3.32 (0.10) 
33273 (372)" 
100 
During the final 24 h of control or fatty acid treatment of the cardiomyocytes 88 nM [2-3H]-myoinositol (Z&/ml) was 
added. At the end of the preincubation of the cardiomyoctyes with the conditioned media the (polyphospho)PI lipids 
were extracted, separated on TLC and counted b 
(PI + PIP + PIP,). Incorporation is expressed as 1 
liquid scintillation. Sum means total (polyphospho)PI lipids 
dpm/4-well multidish and as ' % of the total (polyphospho)PI 
lipid fraction. Values are presented as means (S.E.) of 16 experiments a P<O.O5 vs control cells. 
days lasting incubation of cardiomyocytes 
with control or fatty acid supplemented 
medium has also been measured (Table 6). 
The relative distribution of [3H]-inositol into 
PI, PIP and PIP, remained unaffected by the 
fatty acid treatments. It should be noticed that 
PIP:! constitutes only about 3.5% of the total 
(polyphospho)PI lipid fraction. The absolute 
[3H]-inositol incorporation in PI, PIP and 
PIP? was 30% reduced by 20:5n-3, but only 
10% by 18:2n-6 treatment of the cardiomyo- 
cytes. No effect was observed when the cardio- 
myocytes were treated with 18:0/18:ln-g. 
Cellular TG content and the rate of lipolysis 
In order to explore the effect of fatty acid 
treatment of cardiomyocytes on neutral lipid 
metabolism, the cellular TG contents and 
rates of lipolysis were measured [Fig. 3(B)]. A 
large increase of cellular TG content and rate 
of lipolysis was seen after fatty acid treatment. 
The increases were not much dependent of the 
type of fatty acid treatment, although the 
glycerol release in 20:5n-3 treated cells was 
significantly higher than that in 18:0/18:1n-9 
treated cells. Stimulation of the cells by 
phenylephrine (3OpM) did not affect the rate 
of lipolysis. 
Discussion 
Fatty acid composition of membrane phospholipids 
To delineate the mechanism(s) of the reported 
reduction of the ari-adrenergic inotropic 
response by dietary n-3 vs. n-6 PUFA in the 
Langendorff perfused rat heart (Reibel et al., 
1988), we studied rat neonatal cardiomyocytes 
cultured in fatty acid enriched media. This 
preparation has severai advantages: (i) it 
allows the examination of the olt-adrenoceptor 
mediated PI response in the cardiomyocyte 
free from other cell types in the myocardium 
(e.g. vascular smooth muscle and endothelial 
cells) known to possess an active PI turnover; 
(ii) cardiomyocytes survive in culture medium 
for several days allowing incorporation in uitro 
of specific fatty acids into cell membrane 
phospholipids and (iii) the myocyte poly- 
phosphoinositide pool is more accessible for 
radioactive labelling with [‘HI-myoinositol 
than in whole heart preparations. 
As a consequence of supplementation of the 
culture medium with fatty acids the cardio- 
myocyte phospholipid composition varied 
widely, whereas its phospholipid class contents 
and composition were unchanged. In our 
experiments the total NEFA pool in the media 
varied between 30gM (control treated cells) 
and 24OpM (fatty acid treated cells), concent- 
rations which are less than twice the albumin 
concentration in the added sera. The albumin 
prevents fatty acid toxicity based on our 
previous observations that cardiac sarco- 
lemmal membrane integrity is affected when 
NEFA to albumin molar ratio exceeds 5 
(Lamers et al., 1984). Furthermore, intra- 
cellular accumulation of NEFA was prevented 
by incorporation into TG. Indeed, the present 
study shows fatty acid treatment induced 
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accumulation of TG in the cardiomyocytes 
and this effect has been reported for other 
cultured cell preparations (Spector et al., 
1981). The rate of TG synthesis is primarily 
determined by the availability of initial sub- 
strates glycerol-3-phosphate and acylCoA, 
which are derived from stored glycogen (or 
extracellular glucose) and NEFA (Stam et al., 
1987), respectively. The TG accumulation 
likely was harmless as the cells continue to 
beat spontaneously at a constant rate (data not 
shown), although possible changes in the 
amplitude of contraction had not been 
measured. Hasin et al. (1982) cultured neo- 
natal rat heart cells for up to 16 days in 
medium containing 20% animal sera supple- 
mented with 5OpM 18:0 or 18:2n-6 with no 
apparent loss of viability. 
The predicted elevations of 18: ln-9, 18:2n-6 
and 20:5n-3 associated with a partial depletion 
of 20:4n-6 were confirmed in all phospholipid 
classes except for SPM, of the respective 
groups of fatty acid treated cells. In the 
20:5n-3 treatment group, the change in 
n-3/n-6 PUFA molar ratio of e.g. the major 
phospholipid class PC from 0.17 to 2.11 was 
even more pronounced than that reported by 
Reibel et al. (1988) for the total phospholipid 
fraction (from 0.31 to 1.14) after feeding rats 
with fish oil. In spite of the similar patterns of 
changes, each phospholipid class had an 
unique fatty acid composition and a distinct 
response to the fatty acid treatments. In 
particular, the PI fraction, which was very 
homogeneous in fatty acid composition in 
control treated cells, changed dramatically 
after the fatty acid treatments. The results of 
the control treated cells showed that 20:4n-6 is 
enriched (30.0%) in the PI fraction and that 
the other major fatty acid appeared to be 18:0 
(39.2 mol%). These findings are in agreement 
with the generally accepted, but not experi- 
mentally proven, proposal in the literature 
that the sn-2 position of PIP, mainly is 
occupied by 20:4n-6, which is released in the 
form of DG after receptor-mediated stimulat- , 
ion of PIP, hydrolysis (Berridge, 1984). This 
homogeneity in the PI fraction was no longer 
apparent when the cells were treated with 
18:0/18:1n-9, 18:2n-6 or 20:5n-3. In the 
18:0/18: ln-9 treated cells 18: ln-9 was 
incorporated into PI to a large extent (from 
6.5 to 18.3 mol%) in contrast to the 18:0 
content of PI which actually decreased (from 
39.2 to 34.0 mol%). In the 18:2n-6 treated 
cells 18:2n-6 is incorporated into PI to a large 
extent (from 4.4 to 17.4 mol%) and even more 
avidly into PC (from 14.0 to 42.1 mol%). In 
the 20:5n-3 treated cells, both 20:4n-6 and 
20:5n-3 were enriched in the PI fraction (12.9 
and 20.6%) respectively). In general it can be 
concluded that the main effect of all three fatty 
acid treatments on the various phospholipid 
classes was a partial replacement of the 
20:4n-6. 
No desaturation of 18:2n-6 occurred which 
finding is in agreement with the results 
reported by Hagve and Sprecher (1989). We 
were also able to show that neonatal rat heart 
myocytes have the capacity to elongate C20 
fatty acids. This was not observed by Hagve 
and Sprecher (1989) who studied the meta- 
bolism of labelled 20:5n-3 in cardiomyocytes 
isolated, but not cultured, from the adult rat 
heart. 
Rates of basal and cr&renoceptor mediated PIP, 
hydrolysis 
The rate of basal and arl-adrenoceptor medi- 
ated PI turnover was largely affected by the 
changes in fatty acid composition of PI and/or 
all other phospholipid classes. Apart from the 
observed reductions in the basal rates, the 
phenylephrine (30 PM) stimulated production 
of inositolphosphates was reduced by 51% and 
71%, respectively in the 18:2n-6 and 20:5n-3 
treated cardiomyocytes. The basal rate of 
inositolphosphate formation was 37% 
increased in the 18:0/18:1n-9 treated cells. 
Under the present experimental conditions, 
the NEFA added to the culture medium were 
washed away prior to the activation of PIP, 
breakdown. Therefore it is unlikely, that a 
direct activation of protein kinase C by extra- 
cellularly derived PUFA is involved in the 
observed decrease in the rate of PIP, break- 
down induced by n-6 or n-3 PUFA treatment 
of the cardiomyocytes (McPhail et al., 1984 
and Meij and Lamers, 1989b). Thus the 
effects on the PI cycle in this study can be 
attributed to the different composition of the 
membrane lipids. Since the changes of the 
various phospholipid classes induced by the 
fatty acid treatment were complex, it is not 
possible to identify one of them, e.g. a change 
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of n-3/n-6 PUFA molar ratio, CPUFA, or 
20:4n-6 content of PI, to be causally related to 
the changes in basal and/or art-adrenoceptor 
mediated rate of PIP2 breakdown. Therefore 
no firm conclusions can be drawn from the 
results of the present study to explain the 
possible mechanism(s) of changes in the rate 
of PIP2 breakdown. One possible mechanism 
would be that the fatty acids induce changes in 
the membrane content of PIP,. For this 
reason we measured the [3H]-inositol 
incorporation during the final 24 h of the three 
days lasting incubation of cardiomyocytes 
with control or fatty acid supplemented 
medium. The relative distribution of 
[3H]-inositol into PI, PIP and PIP2 remained 
unaffected by the fatty acid treatments. The 
latter indicates that the equilibrium concen- 
trations of these lipids are well maintained by 
active PI- and PIP-kinases and active PIP and 
PIP2-phosphatases. The absolute [3H]-inositol 
incorporation in PI, PIP and PIP* was 28% 
reduced by 20:5n-3, but only 12% by 18:2n-6 
treatment of the cardiomyocytes. Therefore, a 
partial contribution of PUFA-induced 
reduction of the PIP* level to the attenuation 
of basal and ar,-adrenoceptor mediated IP, 
production can not be excluded, At present it 
is not clear how PUFA cause a reduction of 
[3H]-inositol incorporation into the (poly- 
phospho)PI lipids. They may interact with 
several enzymatic steps in the regeneration of 
PI from IP, and DG or with the transport of 
inositol across the plasma membrane. 
Reibel et al. (1988) demonstrated that 
dietary n-3 PUFA result in a reduction of the 
al-adrenergic inotropic response. The present 
data on 20:5n-3 treatment of cultured cardio- 
myocytes offer a possible mechanism of action 
of dietary n-3 PUFA via the IPs pathway and 
unlikely involving the eicosanoid pathway. 
Indeed, Reibel et al. (1988) showed already 
that changes in eicosanoid production were 
unrelated to the effects of dietary fish oil on 
(Y t -adrenergic stimulation. The reduced 
cr,-adrenergic response caused by dietary n-3 
PUFA could protect the myocardium against 
the pathophysiological consequences of cate- 
cholamine release evoked by chronic adren- 
ergic or ischemic stress (Gudbjarnason et al., 
1978 and Hartog et al., 1987). 
Fat& acid composition of PI after prolonged 
cy,-adrcnergic stimulation 
Previously we demonstrated that maximal 
stimulation by phenylephrine over a pro- 
longed period (30min) did not reduce the PI, 
PIP and PIP* contents of the cardiomyocyte 
membranes (Meij and Lamers, 1989b). This 
means that the cells have the capacity to 
rapidly resynthesize PI from CDP-diacyl- 
glyceride and inositol and subsequently to 
polyphosphorylate PI. A change in the PI 
fatty acid composition after prolonged 
stimulation of the PI cycle would be likely to 
occur, because the resynthesized PI will 
obtain its precursor fatty acids from a mixed 
pool of diacylglycerides (DG). In the present 
study no significant depletion of any of the 
PUFA occurred in the cY,-adrenergic 
stimulated cardiomyocytes, not even in the PI 
fraction. We (Montfoort et al., 1986) and 
others (Gudbjarnason et al., 1978) have shown 
that chronic noradrenaline stress in rats 
resulted in an increase in n-3/n-6 PUFA molar 
ratio of the total phospholipid fraction. Based 
on the present results this stress effect may be 
purely of P-adrenergic nature. However, the 
latter hypothesis should be tested using a /3- 
adrenergic agonist in the incubation of the 
cultured cardiomyocytes. 
In conclusion, variations in the PUFA 
composition of membrane phospholipids do 
affect the basal and the at-adrenoceptor 
stimulated rate of PIP, hydrolysis. The reduc- 
ing effects of 18:2n-6 and 20:5n-3 treatment 
may be partially ascribed to lowering of PIP,! 
levels. 
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